Webster J, Robb O J, Jeffers T A, Scott A K, Petrie J C
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Scotland.
J Cardiovasc Pharmacol. 1988;12 Suppl 7:S72-5. doi: 10.1097/00005344-198812007-00016.
The antihypertensive efficacy of once-daily amlodipine was studied in a group of 30 patients with mild to moderate hypertension in a double-blind, placebo-controlled, parallel-group study. The dose range of amlodipine was 2.5-10.0 mg daily adjusted every 2 weeks for a total treatment period of 8 weeks. Amlodipine produced a significant reduction in blood pressure compared with placebo, the mean difference between baseline and 8 weeks (corrected for placebo effect) being 16/12 mm Hg supine, 14/4 mm Hg standing. Blood pressure returned to baseline values during a terminal 4-week washout period with placebo. There were no significant effects on heart rate. Two patients experienced slight ankle edema while receiving amlodipine 10.0 mg daily but the active drug was otherwise well tolerated.
在一项双盲、安慰剂对照、平行组研究中,对30例轻至中度高血压患者研究了每日一次氨氯地平的降压疗效。氨氯地平的剂量范围为每日2.5 - 10.0毫克,每2周调整一次,总治疗期为8周。与安慰剂相比,氨氯地平使血压显著降低,基线与8周时(校正安慰剂效应)的平均差异为仰卧位16/12毫米汞柱,站立位14/4毫米汞柱。在为期4周的最终洗脱期使用安慰剂时,血压恢复至基线值。对心率无显著影响。两名患者在每日服用10.0毫克氨氯地平时出现轻微踝部水肿,但活性药物在其他方面耐受性良好。